HSU, MING-CHU,KING, CHI-HSIN RICHARD,CHEN, SHU-JEN,LIN, LUKE
申请号：
NZ58889808
公开号：
NZ588898A
申请日:
2008.09.08
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of nemonoxacin (formula I) and its enantiomers for treating infections caused by antibiotic-resistant Staphylococcus aureus, particularly, community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Nemonoxacin is 7-[3-amino-5-methyl-1-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid.
